Skip to main content
Clinical Trials/CTRI/2020/06/026232
CTRI/2020/06/026232
Not Yet Recruiting
Phase 3

A Clinical Trial to Study the Efficacy of â??Ivermectinâ?? in the prevention of Covid-19. .A Single Arm Study. â??

DVFM0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
DVFM
Status
Not Yet Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
DVFM

Eligibility Criteria

Inclusion Criteria

  • Subjects who are not suffering from active illness due to infection at the time of inclusion .

Exclusion Criteria

  • 1\.Pregnant and lactating women.
  • 2\.Subjects suffering from active illness due to infection at the time of inclusion.
  • 3\.Subjects suffering from uncontrolled DM, HTN etc
  • 4\.Subjects who are known cases of immune\-compromised or autoimmune condition such as HIV.

Outcomes

Primary Outcomes

Not specified

Similar Trials